Edwin Choy, MD, PhD
MGH, Dana Farber/Harvard Cancer Center · Massachusetts General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Edwin Choy, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:03 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02303262 · SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic LeiomyosarcomaSarcoma Alliance for Research through Collaboration · completed · Metastatic Leiomyosarcoma · principal investigator
- Ph1NCT01858168 · Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or RhabdoomyosarcomaMassachusetts General Hospital · completed · Ewing Sarcoma, Rhabdomyosarcoma · principal investigator
- Ph2NCT01583543 · Olaparib in Adults With Recurrent/Metastatic Ewing's SarcomaMassachusetts General Hospital · completed · Ewing's Sarcoma
- Ph1NCT01407198 · Nilotinib With Radiation for High Risk ChordomaMassachusetts General Hospital · completed · Chordoma · principal investigator
- Ph1/Ph2NCT01027910 · PCI-24781 in Combination With Doxorubicin to Treat SarcomaMassachusetts General Hospital · completed · Sarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.